Loading...
Cochlear Limited
COH.AX•ASX
HealthcareMedical - Devices
$265.80
$-1.75(-0.65%)
Cochlear Limited (COH.AX) Stock Overview
Explore Cochlear Limited’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
15.47%
↑ 15.47%
Profit Growth
$5.65
↑ 18.70%
EPS Growth
$5.65
↑ 19.04%
Operating Margin
22.78%
↑ 26.45%
ROE
19.98%
↑ 18.70%
Dividend Yield
0.00%
↑ 24.91%
Analyst Recommendations data is not available for COH.AXAnalyst Recommendations details for COH.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
CEO
Mr. Diggory William Howitt BE (Hons), MBA
Employees
4,996
Headquarters
1 University Avenue, Sydney, NSW
Founded
1995